CS logo
small CS logo
Centre Jean Perrin

Clermont Ferrand, France
Cancer treatment center in Clermont-Ferrand
58 Rue Montalembert, 63011 Clermont-Ferrand

About Centre Jean Perrin


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
UNICANCER
56
Centre Jean Perrin
40
European Organisation for Research and Treatment of Cancer - EORTC
29
ARCAGY/ GINECO GROUP
17
Centre Leon Berard
14
Centre Oscar Lambret
12
Hoffmann-La Roche
11
Institut Claudius Regaud
10
Institut Cancerologie de l'Ouest
7
Institut Curie
7
University Hospital, Clermont-Ferrand
7
Total Rows: 71

Clinical Trials at Centre Jean Perrin


During the past decade, Centre Jean Perrin conducted 173 clinical trials. In the 10-year time frame, 173 clinical trials started and 20 clinical trials were completed, i.e. on average, 11.6% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 12 clinical trials were completed. i.e. 19% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1717151517173030313125251818171733110022114411553333Started TrialsCompleted Trails201520162017201820192020202120222023010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1996-05-01
Completed
342
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1994-12-01
2002-01-01
Completed
180
Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
1995-07-01
Completed
25
Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors
1996-02-01
Completed
40
MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors
1997-04-01
Completed
5
Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
1997-05-01
Completed
200
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
1998-03-01
Completed
554
Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer
1998-12-01
Completed
80

Rows per page:

1–100 of 307

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centre Jean Perrin" #1 sponsor was "UNICANCER" with 56 trials, followed by "Centre Jean Perrin" with 40 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 29 trials sponsored, "ARCAGY/ GINECO GROUP" with 17 trials sponsored and "Centre Leon Berard" with 17 trials sponsored. Other sponsors include 146 different institutions and companies that sponsored additional 71 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Jean Perrin" #1 collaborator was "National Cancer Institute, France" with 14 trials as a collaborator, "AstraZeneca" with 12 trials as a collaborator, "Pfizer" with 8 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 7 trials as a collaborator and "Roche Pharma AG" with 7 trials as a collaborator. Other collaborators include 208 different institutions and companies that were collaborators in the rest 159 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUNICANCER: 56UNICANCER: 56Centre Jean Perrin: 40Centre Jean Perrin: 40European Organisationfor Research andTreatment of Cancer -EORTC: 29European Organisationfor Research andTreatment of Cancer -EORTC: 29ARCAGY/ GINECO GROUP: 17ARCAGY/ GINECO GROUP: 17Centre Leon Berard: 14Centre Leon Berard: 14Centre Oscar Lambret: 12Centre Oscar Lambret: 12Hoffmann-La Roche: 11Hoffmann-La Roche: 11Institut Claudius Regaud: 10Institut Claudius Regaud: 10Institut Cancerologie del'Ouest: 7Institut Cancerologie del'Ouest: 7Institut Curie: 7Institut Curie: 7

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute, France: 14National CancerInstitute, France: 14AstraZeneca: 12AstraZeneca: 12Pfizer: 8Pfizer: 8ARCAGY/ GINECO GROUP: 7ARCAGY/ GINECO GROUP: 7Roche Pharma AG: 7Roche Pharma AG: 7Merck Sharp & Dohme LLC: 6Merck Sharp & Dohme LLC: 6Fondation ARC: 5Fondation ARC: 5Hoffmann-La Roche: 5Hoffmann-La Roche: 5Novartis: 5Novartis: 5UNICANCER: 5UNICANCER: 5

Clinical Trials Conditions at Centre Jean Perrin


According to Clinical.Site data, the most researched conditions in "Centre Jean Perrin" are "Breast Cancer" (48 trials), "Ovarian Cancer" (20 trials), "Metastatic Breast Cancer" (10 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (9 trials) and "Cancer" (7 trials). Many other conditions were trialed in "Centre Jean Perrin" in a lesser frequency.

Clinical Trials Intervention Types at Centre Jean Perrin


Most popular intervention types in "Centre Jean Perrin" are "Drug" (200 trials), "Other" (51 trials), "Procedure" (39 trials), "Biological" (28 trials) and "Radiation" (23 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "cyclophosphamide" (11 trials), "fluorouracil" (11 trials), "Pembrolizumab" (10 trials) and "Trastuzumab" (10 trials). Other intervention names were less common.

Clinical Trials Genders at Centre Jean Perrin


The vast majority of trials in "Centre Jean Perrin" are 179 trials for "All" genders, 106 trials for "Female" genders and 22 trials for "Male" genders.

Clinical Trials Status at Centre Jean Perrin


Currently, there are NaN active trials in "Centre Jean Perrin". 1 are not yet recruiting, 77 are recruiting, 55 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 132 completed trials in Centre Jean Perrin, 3 suspended trials, and 23 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Jean Perrin, 16 "Phase 1" clinical trials were conducted, 108 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 64 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 108Phase 2: 108Phase 3: 90Phase 3: 90Not Applicable: 64Not Applicable: 64Phase 1: 16Phase 1: 16Early Phase 1: 2Early Phase 1: 2Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 132Completed: 132Recruiting: 77Recruiting: 77Active, not recruiting: 55Active, not recruiting: 55Terminated: 23Terminated: 23Unknown status: 11Unknown status: 11Withdrawn: 5Withdrawn: 5Suspended: 3Suspended: 3Not yet recruiting: 1Not yet recruiting: 1